Regulation of ACAT activity by a cholesterol substrate pool during the progression and regression phases of atherosclerosis: implications for drug discovery

This publication has 55 references indexed in Scilit:

• Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes
  The American Journal of Cardiology, 1989
• Inhibition of cellular cholesterol esterification can decrease low density lipoprotein receptor number in human fibroblasts
  Biochemical and Biophysical Research Communications, 1987
• Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis.
  Journal of Clinical Investigation, 1984
• Activity of acyl-CoA: Cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl-CoA reductase in subfractions of hepatic microsomes enriched with cholesterol
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
• Dual modulation of hepatic and intestinal acyl‐CoA: cholesterol acyltransferase activity by (de‐)phosphorylation and substrate supply in vitro
  FEBS Letters, 1983
• Properties of a solubilised and reconstituted preparation of ACYL-CoA:cholesterol acyltransferase from rat liver
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
• Comparative effects of cetaben (PHB) and dichlormethylene diphosphonate (Cl2MDP) on the development of atherosclerosis in the cynomolgus monkey
  Atherosclerosis, 1978
• Cellular Mechanisms for Lipid Deposition in Atherosclerosis
  New England Journal of Medicine, 1977
• Cellular Mechanisms for Lipid Deposition in Atherosclerosis
  New England Journal of Medicine, 1977
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976